https://orcid.org/0000-0001-9175-5051
About the Authors
- Olivier Hermine
-
Roles Conceptualization, Writing – review & editing
* E-mail: ohermine@gmail.com
Affiliations Imagine Institute, INSERM UMR 1163, University of Paris, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implication, Hôpital Necker, Paris, France, Department of Hematology, Necker Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
- Laurent Gros
-
Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing
Affiliation AB Science, Paris, France
- Truong-An Tran
-
Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing
Affiliation AB Science, Paris, France
- Lamya Loussaief
-
Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing
Affiliation AB Science, Paris, France
- Kathleen Flosseau
-
Roles Conceptualization, Data curation, Writing – review & editing
Affiliation AB Science, Paris, France
- Alain Moussy
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation AB Science, Paris, France
- Colin D. Mansfield
-
Roles Formal analysis, Writing – original draft, Writing – review & editing
Affiliation AB Science, Paris, France
- Patrick Vermersch
-
Roles Conceptualization, Writing – review & editing
Affiliation Univ. Lille, UMR Inserm U1172, CHU Lille, FHU Precise, Lille, France
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: Masitinib is under clinical development by the study funder, AB Science. AM, CDM, KF, LG, LL, OH, and TAT are employees and/or shareholders of AB Science. PV reports honoraria and consulting fees from Biogen, Sanofi-Genzyme, Novartis, Teva, Merck, Roche, Celgene, Imcyse and AB Science; and research grants from Sanofi-Genzyme, Roche and Merck.